Mauritian bizman gets life-saving liver treatment in city hospital

Anshita Mehra

New Delhi, July 26

Jason, a 49-year-old businessman from Port Louis, Mauritius, has triumphed over a severe liver ailment after a challenging medical journey.

Initially diagnosed with Non-Alcoholic Steatohepatitis (NASH), a condition characterised by fat accumulation in the liver, Jason’s illness progressed to Hepatocellular Carcinoma (HCC), a form of liver cancer complicated by portal vein invasion. The HCC is a major health concern, contributing to over 12,000 deaths annually in the USA.

After undergoing extensive treatments in Mauritius with no significant improvement, Jason sought advanced care at Sir Ganga Ram Hospital in New Delhi. Under the guidance of Dr. Arun Gupta, chairperson of the department of interventional radiology, Jason was treated with Y-90 transarterial radioembolisation. This cutting-edge, minimally invasive procedure combines embolisation and radiation therapy to target liver cancer.

“Y-90 transarterial radioembolisation represents a significant advancement in the treatment of hepatocellular carcinoma,” Dr Gupta said. “By delivering targeted radiation directly to the tumour through microscopic beads, we can effectively halt its growth.”

The procedure involves injecting radioactive microspheres containing Yttrium-90 (Y-90) into the blood vessels feeding the tumour. These microspheres emit targeted radiation, destroying cancer cells internally while preserving surrounding healthy tissue. Jason’s post-procedure progress is being closely monitored, with early imaging results indicating a reduction in tumour size and an improvement in his quality of life.

Dr Gupta highlighted the importance of this advanced treatment, stating, “With innovations like Y-90 transarterial radioembolisation and improvements in dosimetry, we are better equipped to manage hepatocellular carcinoma.” Jason’s case emphasises the critical role of early detection and timely intervention in managing liver cancer. “The transition from NASH to the HCC can be slow and gradual, often spanning several years,” Dr Gupta noted.